Skip to main content
Erschienen in: Clinical Rheumatology 7/2016

20.05.2016 | Original Article

Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients

verfasst von: Paolo Sfriso, Roberta Priori, Guido Valesini, Silvia Rossi, Carlo Maurizio Montecucco, Anna D’Ascanio, Linda Carli, Stefano Bombardieri, Gaetana LaSelva, Florenzo Iannone, Giovanni Lapadula, Stefano Alivernini, Gianfranco Ferraccioli, Michele Colaci, Clodoveo Ferri, Daniela Iacono, Gabriele Valentini, Luisa Costa, Raffaele Scarpa, Andrea LoMonaco, Valentina Bagnari, Marcello Govoni, Ilaria Piazza, Silvano Adami, Francesco Ciccia, Giovanni Triolo, Elisa Alessandri, Maurizio Cutolo, Luca Cantarini, Mauro Galeazzi, Piero Ruscitti, Roberto Giacomelli, Francesco Caso, Paola Galozzi, Leonardo Punzi

Erschienen in: Clinical Rheumatology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Adult-onset Still’s disease (AOSD) is a systemic inflammatory condition of unknown aetiology characterized by typical episodes of spiking fever, evanescent rash, arthralgia, leukocytosis and hyperferritinemia. Given the lack of data in Italian series, we promote a multicentric data collection to characterize the clinical phenotype of Italian patients with AOSD. Data from 245 subjects diagnosed with AOSD were collected by 15 centres between March and May 2013. The diagnosis was made following Yamaguchi’s criteria. Data regarding clinical manifestations, laboratory features, disease course and treatments were reported and compared with those presented in other published series of different ethnicity. The most frequent features were the following: arthritis (93 %), pyrexia (92.6 %), leukocytosis (89 %), negative ANA (90.4 %) and neutrophilia (82 %). As compared to other North American, North European, Middle Eastern and Far Eastern cohorts, Italian data show differences in clinical and laboratory findings. Regarding the treatments, in 21.9 % of cases, corticosteroids and traditional DMARDs have not been able to control the disease while biologics have been shown to be effective in 48 to 58 patients. This retrospective work summarizes the largest Italian multicentre series of AOSD patients and presents clinical and laboratory features that appear to be influenced by the ethnicity of the affected subjects.
Literatur
3.
Zurück zum Zitat Magadur-Joly G, Billaud E, Barrier JH et al (1995) Epidemiology of adult Still’s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54:587–590CrossRefPubMedPubMedCentral Magadur-Joly G, Billaud E, Barrier JH et al (1995) Epidemiology of adult Still’s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54:587–590CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Cagatay Y, Gul A, Cagatay A et al (2009) Adult-onset Still’s disease. Int J Clin Pract 63:1050–1055CrossRefPubMed Cagatay Y, Gul A, Cagatay A et al (2009) Adult-onset Still’s disease. Int J Clin Pract 63:1050–1055CrossRefPubMed
5.
Zurück zum Zitat Fautrel B, Zing E, Golmard J-L et al (2002) Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 81:194–200CrossRef Fautrel B, Zing E, Golmard J-L et al (2002) Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 81:194–200CrossRef
6.
Zurück zum Zitat Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed
7.
Zurück zum Zitat Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis 65:564–572CrossRefPubMed Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis 65:564–572CrossRefPubMed
8.
Zurück zum Zitat Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P (2014) Adult-onset Still’s disease. Autoimmun Rev 13:708–722CrossRefPubMed Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P (2014) Adult-onset Still’s disease. Autoimmun Rev 13:708–722CrossRefPubMed
9.
Zurück zum Zitat Kong X-D, Xu D, Zhang W, Zhao Y, Zeng X, Zhang F (2010) Clinical features and prognosis in adult-onset Still’s disease: a study of 104 cases. Clin Rheumatol 29:1015–1019CrossRefPubMed Kong X-D, Xu D, Zhang W, Zhao Y, Zeng X, Zhang F (2010) Clinical features and prognosis in adult-onset Still’s disease: a study of 104 cases. Clin Rheumatol 29:1015–1019CrossRefPubMed
10.
Zurück zum Zitat Asanuma YF, Mimura T, Tsuboi H et al (2015) Nationwide epidemiological survey of 169 patients with adult Still’s disease in Japan. Mod Rheumatol 25:393–400CrossRefPubMed Asanuma YF, Mimura T, Tsuboi H et al (2015) Nationwide epidemiological survey of 169 patients with adult Still’s disease in Japan. Mod Rheumatol 25:393–400CrossRefPubMed
11.
Zurück zum Zitat Scirè CA, Cavagna L, Perotti C, Bruschi E, Caporali R, Montecucco C (2006) Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 24:123–128PubMed Scirè CA, Cavagna L, Perotti C, Bruschi E, Caporali R, Montecucco C (2006) Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 24:123–128PubMed
12.
Zurück zum Zitat Priori R, Ceccarelli F, Barone F, Iagnocco A, Valesini G (2008) Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still’s disease. Clin Exp Rheumatol 26:933–937PubMed Priori R, Ceccarelli F, Barone F, Iagnocco A, Valesini G (2008) Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still’s disease. Clin Exp Rheumatol 26:933–937PubMed
13.
Zurück zum Zitat Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG (2010) Adult onset Still’s disease: clinical presentation in a large cohort of Italian patients. Clin Exp Rheumatol 28:41–48PubMed Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG (2010) Adult onset Still’s disease: clinical presentation in a large cohort of Italian patients. Clin Exp Rheumatol 28:41–48PubMed
14.
Zurück zum Zitat Colina M, Zucchini W, Ciancio G, Orzincolo C, Trotta F, Govoni M (2011) The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients. Semin Arthritis Rheum 41:279–285CrossRefPubMed Colina M, Zucchini W, Ciancio G, Orzincolo C, Trotta F, Govoni M (2011) The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients. Semin Arthritis Rheum 41:279–285CrossRefPubMed
15.
Zurück zum Zitat Dall’Ara F, Frassi M, Tincani A, Airò P. A retrospective study of patients with adult-onset Still’s disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol. 2016. [Epub ahead of print] Dall’Ara F, Frassi M, Tincani A, Airò P. A retrospective study of patients with adult-onset Still’s disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol. 2016. [Epub ahead of print]
16.
Zurück zum Zitat Zhang Y, Yang Y, Bai Y, Yang D, Xiong Y, Zeng X. Clinical characteristics and follow-up analysis of adult-onset Still’s disease complicated by hemophagocytic lymphohistiocytosis. Clin Rheumatol. 2016. [Epub ahead of print] Zhang Y, Yang Y, Bai Y, Yang D, Xiong Y, Zeng X. Clinical characteristics and follow-up analysis of adult-onset Still’s disease complicated by hemophagocytic lymphohistiocytosis. Clin Rheumatol. 2016. [Epub ahead of print]
17.
Zurück zum Zitat Cush JJ, Medsger TAJR, Christy WC, Herbert DC, Cooperstein LA (1987) Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum 30:186–194CrossRefPubMed Cush JJ, Medsger TAJR, Christy WC, Herbert DC, Cooperstein LA (1987) Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum 30:186–194CrossRefPubMed
18.
Zurück zum Zitat Kim H-A, Sung J-M, Suh C-H (2012) Therapeutic responses and prognosis in adult-onset Still’s disease. Rheumatol Int 32:1291–1298CrossRefPubMed Kim H-A, Sung J-M, Suh C-H (2012) Therapeutic responses and prognosis in adult-onset Still’s disease. Rheumatol Int 32:1291–1298CrossRefPubMed
19.
Zurück zum Zitat Fautrel B, Le Moël G, Saint-Marcoux B et al (2001) Diagnostic value of ferritin and glycosylated ferritin in adult onset Still’s disease. J Rheumatol 28:322–329PubMed Fautrel B, Le Moël G, Saint-Marcoux B et al (2001) Diagnostic value of ferritin and glycosylated ferritin in adult onset Still’s disease. J Rheumatol 28:322–329PubMed
20.
21.
Zurück zum Zitat Reginato AJ, Schumacher HR Jr, Baker DG et al (1987) Adult onset Still’s disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17:39–57CrossRefPubMed Reginato AJ, Schumacher HR Jr, Baker DG et al (1987) Adult onset Still’s disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17:39–57CrossRefPubMed
22.
Zurück zum Zitat Bisagni-Faure A, Job-Deslandre C, Menkes CJ (1992) Intravenous methylprednisolone pulse therapy in Still’s disease. J Rheumatol 19:1487–1488PubMed Bisagni-Faure A, Job-Deslandre C, Menkes CJ (1992) Intravenous methylprednisolone pulse therapy in Still’s disease. J Rheumatol 19:1487–1488PubMed
23.
Zurück zum Zitat Fautrel B, Borget C, Rozenberg S et al (1999) Corticosteroid sparing effect of low dose methotrexate treatment in adult Still’s disease. J Rheumatol 26:373–378PubMed Fautrel B, Borget C, Rozenberg S et al (1999) Corticosteroid sparing effect of low dose methotrexate treatment in adult Still’s disease. J Rheumatol 26:373–378PubMed
24.
Zurück zum Zitat Dilhuydy MS, Vatan R, Etienne G, Longy-Boursier M, Mercié P (2005) Prolonged efficacy of infliximab for refractory adult-onset Still’s disease. Clin Exp Rheumatol 23:121–122PubMed Dilhuydy MS, Vatan R, Etienne G, Longy-Boursier M, Mercié P (2005) Prolonged efficacy of infliximab for refractory adult-onset Still’s disease. Clin Exp Rheumatol 23:121–122PubMed
25.
Zurück zum Zitat Olivieri I, de Stefano G, Padula A, La Gala A, de Stefano C (2003) Infliximab in a case of early adult-onset Still’s disease. Clin Rheumatol 22:369–370CrossRefPubMed Olivieri I, de Stefano G, Padula A, La Gala A, de Stefano C (2003) Infliximab in a case of early adult-onset Still’s disease. Clin Rheumatol 22:369–370CrossRefPubMed
26.
Zurück zum Zitat Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG (2010) Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still’s disease. Arthritis Rheum 62:2530–2535CrossRefPubMed Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG (2010) Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still’s disease. Arthritis Rheum 62:2530–2535CrossRefPubMed
27.
Zurück zum Zitat Kalliolias GD, Georgiou PE, Antonopoulos IA, Andonopoulos AP, Liossis S-NC (2007) Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Ann Rheum Dis 66:842–843CrossRefPubMedPubMedCentral Kalliolias GD, Georgiou PE, Antonopoulos IA, Andonopoulos AP, Liossis S-NC (2007) Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Ann Rheum Dis 66:842–843CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat de Boysson H, Fevrier J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidence. Clin Rheumatol 32:141–147CrossRefPubMed de Boysson H, Fevrier J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidence. Clin Rheumatol 32:141–147CrossRefPubMed
Metadaten
Titel
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients
verfasst von
Paolo Sfriso
Roberta Priori
Guido Valesini
Silvia Rossi
Carlo Maurizio Montecucco
Anna D’Ascanio
Linda Carli
Stefano Bombardieri
Gaetana LaSelva
Florenzo Iannone
Giovanni Lapadula
Stefano Alivernini
Gianfranco Ferraccioli
Michele Colaci
Clodoveo Ferri
Daniela Iacono
Gabriele Valentini
Luisa Costa
Raffaele Scarpa
Andrea LoMonaco
Valentina Bagnari
Marcello Govoni
Ilaria Piazza
Silvano Adami
Francesco Ciccia
Giovanni Triolo
Elisa Alessandri
Maurizio Cutolo
Luca Cantarini
Mauro Galeazzi
Piero Ruscitti
Roberto Giacomelli
Francesco Caso
Paola Galozzi
Leonardo Punzi
Publikationsdatum
20.05.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 7/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3308-8

Weitere Artikel der Ausgabe 7/2016

Clinical Rheumatology 7/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.